ObesityFUELNCT05562427
Program for Fully Understanding Eating and Lifestyle Change (FUEL)
A study testing Gold-Standard Online Behavioral Obesity Treatment in people with Obesity, run by The Miriam Hospital at 1 site in United States.
Trial summary
This project seeks to better understand dietary lapses (instances of nonadherence to dietary goals), a major cause of poor outcomes during behavioral obesity treatment (BOT). Investigators propose to conduct multimodal real-time assessment of behavioral, psychosocial, and contextual characteristics to uncover lapse… Read more about this study
- Who is it for?
- Ages 18 to 70 years
- Conditions the study is for
- Obesity
- What is being tested?
- Gold-Standard Online Behavioral Obesity Treatment
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 150 participants
- Where
- 1 siteUnited States
- Study dates
- 31 Oct 2022to 30 Apr 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 70 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Ages 18-70
- Body mass index (BMI) between 25 and 50 kg/m-squared
Who cannot join
- Has health problems for which weight loss or physical activity is contraindicated
- Currently pregnant or breastfeeding
- Currently or recently (< 6 months) enrolled in a commercial weight loss program
- Weight loss of ≥ 5% of initial body weight in the last 6 months
- Currently taking weight loss medication,
- Has history of surgical procedure for weight loss,
- Has history of a clinically diagnosed eating disorder excluding Binge Eating Disorder
Trial locations and contacts
1 site in 1 country.
United States1 site
Weight Control and Diabetes Research Center
Providence, Rhode Island, 02903
About this study
Official title: Using Multimodal Real-Time Assessment to Phenotype Dietary Non-Adherence
This project seeks to better understand dietary lapses (instances of nonadherence to dietary goals), a major cause of poor outcomes during behavioral obesity treatment (BOT). Investigators propose to conduct multimodal real-time assessment of behavioral, psychosocial, and contextual characteristics to uncover lapse phenotypes (i.e., meaningful clusters of lapse behaviors, such as lapsing via overeating vs. lapsing via eating an off-plan food). Using wearable sensors and a smartphone-based assessment platform, this research will identify latent characteristics underlying different phenotypes of dietary lapses reported by individuals who are participating in an online BOT. This study will also evaluate how these emerging lapse phenotypes vary over time, between individuals, and within individuals. Such information will ultimately help the field understand how best to reduce lapses in future treatments (e.g., how much to personalize future interventions for lapse vs. generalizability of lapse phenotypes across individuals). Therefore, this study has three goals. First, investigators aim to establish lapse phenotypes by identifying clusters of behavioral, psychosocial, contextual and individual-level factors (e.g., sex, race) that differentiate lapse behaviors during weight loss and maintenance. Second, the investigators aim to test the association of lapse phenotypes with energy intake and weight change during weight loss and maintenance to determine which lapse phenotypes have the greatest impact on BOT outcomes (e.g. personal, environmental, and behavioral factors). Lastly, investigators aim to evaluate individual variability in the occurrence of lapse phenotypes during weight loss and maintenance to determine the generalizability of lapse phenotypes across individuals.
Participants will be recruited through various methods including advertisements in local media, targeted online advertising, advertisements in medical and minority communities, and direct mailers. All participants will receive a well-established online BOT program for 12 months, with a 6-month maintenance period, for a total study participation of 18 months. In conjunction, they will complete 14-day monitoring periods (at baseline, 3 months, 6 months, 12 months, and 18 months) consisting of: 1) repeated daily smartphone surveys to assess personal, environmental, and behavioral factors, including automatic capture of geographic location; 2) wearing two wrist-based sensor devices to passively capture physical activity, sleep, and eating behaviors; and 3) completing telephone-based 24-hour dietary recalls to assess overall energy intake. Weight will be measured at all visits to the research center.
Read the detailed description
The purpose of this 5-year study is to conduct multimodal real-time assessment of behavioral, psychosocial, and contextual characteristics to uncover lapse phenotypes. The data from this project will ultimately inform future personalized interventions to promote dietary adherence by providing critical data on which lapses to target and how to best target them. Participants (N=150) will receive 12 months of online behavioral obesity treatment followed by a 6-month maintenance period (18 months of study participation total). The primary aim is to establish lapse phenotypes by identifying clusters of factors that differentiate lapse behavior. The secondary aim is to evaluate associations of emerging lapse phenotypes with clinical outcomes (e.g., energy intake and weight loss). The investigators will also explore the variability in lapse phenotypes based on data collected from the primary outcome.
Participants will be recruited on a rolling basis until the target (N=150) is reached. Participants will be recruited via advertisements in local media (e.g. newspapers, radio) and online advertising (e.g., Google AdWords, social media), flyers and advertisements posted in waiting rooms and exam rooms in primary care offices, informational materials made available as part of the health and wellness program for employees in the Lifespan hospital network, and direct mailings.
Interested individuals will be initially screened for eligibility via REDCap (a Lifespan secure website) or via telephone. If a participant appears to be eligible based on their responses to the screening questions, they will receive a follow-up call from the research team to confirm eligibility, describe the study in more detail, and schedule an orientation meeting. If they are not eligible, they will receive a message indicating that they are not eligible for the study and directed to contact the research team if they wish to receive referrals for other weight loss programs. Those who are eligible will be invited to an orientation via the online video chat forum Zoom, where the study will be described, and informed consent obtained. Only after the consent form is signed will any further study procedures be completed. If consent is not given, participant contact information will be immediately removed from the system. After consent is obtained, participants will complete baseline questionnaires via REDCap. Paper surveys will be made available for participants who prefer this option. If a participant elects to use a paper questionnaire, the questionnaire will be sent to the participant's home address. Participants will then complete a 1-week behavioral run-in in which they complete smartphone-based surveys and wear the sensors. This data is for testing only and will not be used in the analysis of primary outcomes. Participants must complete >70% of EMA surveys and wear both devices >10 hrs/day to move forward with the remainder of study procedures. Following consent and successful completion of baseline procedures, participants will attend an in-person "kick-off" session to assist them in using the online BOT program. Participants will be given access to an online BOT (described further in the Intervention section) for 12 months, with an additional 6 months of no treatment follow-up (intended to serve as a weight maintenance period).
During this 18-month study period, participants will complete 5 total assessments at baseline, 3, 6, 12, and 18 months. Each assessment consists of a 14-day monitoring period. There will be 2 visits with trained research staff at the beginning and end of the 14-day monitoring. At the first visit, participants will: have their height/weight measured, receive study equipment (e.g., wearable wrist devices), and undergo training in using study equipment. Participants will be instructed to wear the sensor devices, complete repeated smartphone surveys for 14 days, and complete three non-consecutive telephone-based 24-hour dietary recalls with staff. At the end of 14 days, participants will return for their second visit in which they will: have their weight measured, return study equipment, and receive payment. The research staff do not need to be blinded for study visits because all participants are assigned to the same intervention. Participants will be asked to complete the same assessment procedures at baseline (first two weeks of the online BOT), 3, 6, 12, and 18 months (last two weeks of no- treatment weight maintenance period).
- Conditions
- Obesity
- Being tested
- Gold-Standard Online Behavioral Obesity Treatment
- Keywords
- Diet, Digital health, Ecological momentary assessment, Behavioral phenotyping, Wearable sensors, Geolocation, Smartphone, Passive sensing, Eating behavior
- Medical subject headings
- Obesity, Feeding Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Gold-Standard Online Behavioral Obesity TreatmentBehavioural
Also called Rx Weight Loss (RxWL)
Rx Weight Loss (RxWL) is an online BOT that consists of: (a) tailored weight loss, calorie, and physical activity goals. (b) 12 weekly 10-15 minute multimedia lessons for training in behavioral weight loss skills followed by 9 monthly lessons for continued weight loss. Lessons incorporate video, animation, audio, quizzes, and exercises for goal setting, planning, and problem-solving. Example topics include restaurant eating, changing the home environment, and obtaining social support. (c) Online tools for self-monitoring weight, diet, and physical activity that interface with popular tracking apps; and (c) Weekly, and eventually monthly, automated feedback on progress to date (delivered as text appearing on the platform). If goals are not met participants receive strategies to improve weight loss, along with encouragement. To ensure engagement, email reminders are sent to participants who have not visited the platform on a given week.
| Study group | Role | What they receive |
|---|---|---|
| 1 | Other | Gold-standard online behavioral weight loss treatment Receives: Behavioral: Gold-Standard Online Behavioral Obesity Treatment |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in dietary lapses
Smartphone-based ecological momentary assessment (EMA) surveys will be used to assess dietary lapses, defined as exceeding a pre-planned calorie target for a given meal or snack. Participants will be asked to report if they experienced a "dietary lapse" since the last EMA survey. Participants can also initiate a report of a dietary lapse at any time. Participants will also record the time that the lapse occurred. Participants will be asked "how would you describe the lapse?" and can select all that apply from: 'I ate a larger portion', 'I ate when I hadn't intended', 'I ate a type of food I wanted to avoid', 'I planned to lapse', 'I did not know the calories in the food.'
Measured: Baseline, 3 months, 6 months, 12 months, and 18 months
Secondary outcomes (2)
Change in weight
Weight will be measured by trained research staff at the research center to the nearest 0.1 kg using a calibrated digital scale. Measurements will be made in light indoor clothing without shoes.
Measured: Baseline, 3 months, 6 months,12 months, and 18 months
Change in energy intake
Participants will complete 3 non-consecutive telephone-based 24-hour dietary recalls. Recalled intake will be collected over 2 weekdays and 1 weekend day. The Nutrition Data System for Research (NDSR), a software application developed at the University of Minnesota Nutrition Nutrition Coordinating Center (NCC), will facilitate collection of recalls in a standardized fashion. Dietary intake interviews will be governed by a multiple-pass interview approach during which participants receive 5 opportunities to recall food intake. Recalled intake and independently observed intake are highly correlated, indicating the 24-hour dietary recall is highly valid and considered the goal-standard of dietary assessment. NDSR will generate daily estimates of usual energy intake using the NCC Food and Nutrient Database.
Measured: Baseline, 3 months, 6 months, 12 months, and 18 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Sep 2022
- Study start31 Oct 2022
- Primary completion30 Apr 2027 (estimated)
- Study completion30 Apr 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for ObesityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 150 participants (estimated)
Sponsor and investigators
- Lead sponsor
- The Miriam Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Stephanie Goldstein, The Miriam Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05562427
- Sponsor's protocol ID
- R01DK132210
- Other IDs
- R01DK132210
- Acronym
- FUEL
- Status last verified
- Mar 2026
- First submitted
- 26 Sep 2022
- Last updated
- 27 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Goldstein SP, Mwenda KM, Hoover AW, Shenkle O, Jones RN, Thomas JG. The Fully Understanding Eating and Lifestyle Behaviors (FUEL) trial: Protocol for a cohort study harnessing digital health tools to phenotype dietary non-adherence behaviors during lifestyle intervention. Digit Health. 2024 Aug 21;10:20552076241271783. doi: 10.1177/20552076241271783. eCollection 2024 Jan-Dec.
PubMed 39175923
Study at a glance
From the registry record, last updated by the sponsor on 27 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Using Multimodal Real-Time Assessment to Phenotype Dietary Non-Adherence
- ClinicalTrials.gov ID
- NCT05562427
- Acronym / sponsor ID
- FUEL / R01DK132210
- Conditions
- Obesity
- Keywords
- Diet, Digital health, Ecological momentary assessment, Behavioral phenotyping, Wearable sensors, Geolocation, Smartphone, Passive sensing
- Study type
- Interventional
- Recruitment status
- Active, not recruiting
- Enrolment
- 150 participants (estimated)
- Lead sponsor
- The Miriam HospitalUniversity, hospital or other
- Collaborators
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Study start
- 31 Oct 2022 (actual)
- Primary completion
- 30 Apr 2027 (estimated)
- Study completion
- 30 Apr 2027 (estimated)
- First posted
- 30 Sep 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This project seeks to better understand dietary lapses (instances of nonadherence to dietary goals), a major cause of poor outcomes during behavioral obesity treatment (BOT). Investigators propose to conduct multimodal real-time assessment of behavioral, psychosocial, and contextual characteristics to uncover lapse phenotypes (i.e., meaningful clusters of lapse behaviors, such as lapsing via overeating vs. lapsing via eating an off-plan food). Using wearable sensors and a smartphone-based assessment platform, this research will identify latent characteristics underlying different phenotypes of dietary lapses reported by individuals who are participating in an online BOT. This study will also evaluate how these emerging lapse phenotypes vary over time, between individuals, and within individuals. Such information will ultimately help the field understand how best to reduce lapses in future treatments (e.g., how much to personalize future interventions for lapse vs. generalizability of lapse phenotypes across individuals). Therefore, this study has three goals. First, investigators aim to establish lapse phenotypes by identifying clusters of behavioral, psychosocial, contextual and individual-level factors (e.g., sex, race) that differentiate lapse behaviors during weight loss and maintenance. Second, the investigators aim to test the association of lapse phenotypes with energy intake and weight change during weight loss and maintenance to determine which lapse phenotypes have the greatest impact on BOT outcomes (e.g. personal, environmental, and behavioral factors). Lastly, investigators aim to evaluate individual variability in the occurrence of lapse phenotypes during weight loss and maintenance to determine the generalizability of lapse phenotypes across individuals.
Participants will be recruited through various methods including advertisements in local media, targeted online advertising, advertisements in medical and minority communities, and direct mailers. All participants will receive a well-established online BOT program for 12 months, with a 6-month maintenance period, for a total study participation of 18 months. In conjunction, they will complete 14-day monitoring periods (at baseline, 3 months, 6 months, 12 months, and 18 months) consisting of: 1) repeated daily smartphone surveys to assess personal, environmental, and behavioral factors, including automatic capture of geographic location; 2) wearing two wrist-based sensor devices to passively capture physical activity, sleep, and eating behaviors; and 3) completing telephone-based 24-hour dietary recalls to assess overall energy intake. Weight will be measured at all visits to the research center.
Detailed description
The purpose of this 5-year study is to conduct multimodal real-time assessment of behavioral, psychosocial, and contextual characteristics to uncover lapse phenotypes. The data from this project will ultimately inform future personalized interventions to promote dietary adherence by providing critical data on which lapses to target and how to best target them. Participants (N=150) will receive 12 months of online behavioral obesity treatment followed by a 6-month maintenance period (18 months of study participation total). The primary aim is to establish lapse phenotypes by identifying clusters of factors that differentiate lapse behavior. The secondary aim is to evaluate associations of emerging lapse phenotypes with clinical outcomes (e.g., energy intake and weight loss). The investigators will also explore the variability in lapse phenotypes based on data collected from the primary outcome.
Participants will be recruited on a rolling basis until the target (N=150) is reached. Participants will be recruited via advertisements in local media (e.g. newspapers, radio) and online advertising (e.g., Google AdWords, social media), flyers and advertisements posted in waiting rooms and exam rooms in primary care offices, informational materials made available as part of the health and wellness program for employees in the Lifespan hospital network, and direct mailings.
Interested individuals will be initially screened for eligibility via REDCap (a Lifespan secure website) or via telephone. If a participant appears to be eligible based on their responses to the screening questions, they will receive a follow-up call from the research team to confirm eligibility, describe the study in more detail, and schedule an orientation meeting. If they are not eligible, they will receive a message indicating that they are not eligible for the study and directed to contact the research team if they wish to receive referrals for other weight loss programs. Those who are eligible will be invited to an orientation via the online video chat forum Zoom, where the study will be described, and informed consent obtained. Only after the consent form is signed will any further study procedures be completed. If consent is not given, participant contact information will be immediately removed from the system. After consent is obtained, participants will complete baseline questionnaires via REDCap. Paper surveys will be made available for participants who prefer this option. If a participant elects to use a paper questionnaire, the questionnaire will be sent to the participant's home address. Participants will then complete a 1-week behavioral run-in in which they complete smartphone-based surveys and wear the sensors. This data is for testing only and will not be used in the analysis of primary outcomes. Participants must complete >70% of EMA surveys and wear both devices >10 hrs/day to move forward with the remainder of study procedures. Following consent and successful completion of baseline procedures, participants will attend an in-person "kick-off" session to assist them in using the online BOT program. Participants will be given access to an online BOT (described further in the Intervention section) for 12 months, with an additional 6 months of no treatment follow-up (intended to serve as a weight maintenance period).
During this 18-month study period, participants will complete 5 total assessments at baseline, 3, 6, 12, and 18 months. Each assessment consists of a 14-day monitoring period. There will be 2 visits with trained research staff at the beginning and end of the 14-day monitoring. At the first visit, participants will: have their height/weight measured, receive study equipment (e.g., wearable wrist devices), and undergo training in using study equipment. Participants will be instructed to wear the sensor devices, complete repeated smartphone surveys for 14 days, and complete three non-consecutive telephone-based 24-hour dietary recalls with staff. At the end of 14 days, participants will return for their second visit in which they will: have their weight measured, return study equipment, and receive payment. The research staff do not need to be blinded for study visits because all participants are assigned to the same intervention. Participants will be asked to complete the same assessment procedures at baseline (first two weeks of the online BOT), 3, 6, 12, and 18 months (last two weeks of no- treatment weight maintenance period).
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| 1 | Other | Behavioral: Gold-Standard Online Behavioral Obesity TreatmentGold-standard online behavioral weight loss treatment |
Who may qualify
- Ages
- 18 to 70 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- Ages 18-70
- Body mass index (BMI) between 25 and 50 kg/m-squared
Key exclusion criteria (7 listed)
- Has health problems for which weight loss or physical activity is contraindicated
- Currently pregnant or breastfeeding
- Currently or recently (< 6 months) enrolled in a commercial weight loss program
- Weight loss of ≥ 5% of initial body weight in the last 6 months
- Currently taking weight loss medication,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Gold-Standard Online Behavioral Obesity TreatmentAlso: Rx Weight Loss (RxWL)Rx Weight Loss (RxWL) is an online BOT that consists of: (a) tailored weight loss, calorie, and physical activity goals. (b) 12 weekly 10-15 minute multimedia lessons for training in behavioral weight loss skills followed by 9 monthly lessons for continued weight loss. Lessons incorporate video, animation, audio, quizzes, and exercises for goal setting, planning, and problem-solving. Example topics include restaurant eating, changing the home environment, and obtaining social support. (c) Online tools for self-monitoring weight, diet, and physical activity that interface with popular tracking apps; and (c) Weekly, and eventually monthly, automated feedback on progress to date (delivered as text appearing on the platform). If goals are not met participants receive strategies to improve weight loss, along with encouragement. To ensure engagement, email reminders are sent to participants who have not visited the platform on a given week. | Behavioural | 1 |
Primary outcome
Change in dietary lapses
Time frame: Baseline, 3 months, 6 months, 12 months, and 18 months
Smartphone-based ecological momentary assessment (EMA) surveys will be used to assess dietary lapses, defined as exceeding a pre-planned calorie target for a given meal or snack. Participants will be asked to report if they experienced a "dietary lapse" since the last EMA survey. Participants can also initiate a report of a dietary lapse at any time. Participants will also record the time that the lapse occurred. Participants will be asked "how would you describe the lapse?" and can select all that apply from: 'I ate a larger portion', 'I ate when I hadn't intended', 'I ate a type of food I wanted to avoid', 'I planned to lapse', 'I did not know the calories in the food.'
2 secondary outcomes
Change in weight
Time frame: Baseline, 3 months, 6 months,12 months, and 18 months
Change in energy intake
Time frame: Baseline, 3 months, 6 months, 12 months, and 18 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Mar 2026.
- Derived from this study: PubMed 39175923Goldstein SP, Mwenda KM, Hoover AW, Shenkle O, Jones RN, Thomas JG. The Fully Understanding Eating and Lifestyle Behaviors (FUEL) trial: Protocol for a cohort study harnessing digital health tools to phenotype dietary non-adherence behaviors during lifestyle intervention. Digit Health. 2024 Aug 21;10:20552076241271783. doi: 10.1177/20552076241271783. eCollection 2024 Jan-Dec.
Related trials for Obesity
Not yet recruitingObservational study
Assessing the Impact of Perceptions of Unpredictability on Objective Measures of Food Consumption and Metabolism
Healthy Volunteer, Obestity
RecruitingPhase 3
Trial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Metabolic Dysfunction-Associated Steatotic Liver Disease, MASLD
Recruiting
Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change
Overweight, Obesity
RecruitingPhase 1
Evaluate the Safety and Tolerability of Multiple Doses of JMT206 Injection in Obese Participants
Valid MeSH Conditiongs
Not yet recruiting
Prospective Evaluation of Recombinant Pbserum Plus® and Pbserum HA 2.0® in Aesthetic and Regenerative Bioremodeling
Skin Laxity, Localized Adiposity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Gold-Standard Online Behavioral Obesity Treatment in people with Obesity, run by The Miriam Hospital at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 27 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in dietary lapses (time frame: Baseline, 3 months, 6 months, 12 months, and 18 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05562427, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Mar 2026.